Novo Nordisk AS New Product Development Pipeline

• Publication date: August 2008
• Report size: 40 pages

The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development. Report Coverage • Details of development stage by segment and equipment type. • Pipeline products grouped by therapy area, development stage and trial phase. • Detailed data on clinical trials covering trial phase, descrip...

The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Report Coverage

• Details of development stage by segment and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed data on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• About this Report s of novel technologies relating to new product development of the firm .
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Why Should You Get This Report?

• A single source to fulfill competitor information relating to products in development.
• Identify new product development that are potential competitor to your product lines.
Understand a firm 's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted industry ing activities.
• Take corrective measures on your own development programs and Research and Development initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and industry ing partners.
• Helps avoid patent infringement.
• Timelines from concept to industry lets you keep track of industry potential build for a new product.
Assess a firm 's future growth by determining its pipeline depth, for probable take over opportunities.

Global Medical Devices Industry

1 Table of Contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 7

II Company Snapshot 8
II. 1 Facts and Figures 8
II. 2 Company Profile 8
II. 3 Financial Performance 8
II. 4 Market Outlook – In Vitro Diagnostics 8
3 Business Overview 9
III. 1 Business Description 9
III. 2 Major Products and Services 9
III. 2.1 Overview 9

IV History 11

V Competitors 13
6 Key Executives 14

VII Key Employee Biographies 15

VIII Company Statement 17
9 Operations and Subsidiaries 20
IX. 1 Headquarter 20
IX. 2 Other Locations & Subsidiaries 20

X Recent Developments 22
X. 1 Financial Announcements 22
X. 1.1 August 07, 2008: November o Reports 1H 2008 Results 22
X. 1.2 April 30, 2008: November o Reports Q1 2008 Results 24
X. 1.3 January 31, 2008: November o Reports 2007 Results 26
X. 1.4 October 31, 2007: November o December lares Nine Months Ended 2007 Results 28
X. 1.5 August 03, 2007: November o Reports H1 2007 Results 29
X. 1.6 May 02, 2007: November o Reports Q1 2007 Results 30
X. 1.7 January 31, 2007: November o Reports 2006 Results 31
X. 2 Product News 32
X. 2.1 September 11, 2001: InDuo Is Launched To Help Improve Diabetes Management 32

XI November o Nordisk A/S Pipeline Products 33
XI. 1 November o Nordisk A/S Product Pipeline Analysis 33
XI. 1.1 November o Nordisk A/S Pipeline Products By Equipment Type 33
XI. 1.2 November o Nordisk A/S Pipeline Products By Development Stage 34
XI. 1.3 November o Nordisk A/S Pipeline Products By Therapy Area 35
XI. 2 Future Inhalation Systems 35
XI. 2.1 Product Description 35
XI. 2.2 Product Status 35
XI. 3 Future Insulin Infusion Systems 35
XI. 3.1 Product Description 35
XI. 3.2 Product Status 36
XI. 4 Next Generation Durable Pen 36
XI. 4.1 Product Description 36
XI. 4.2 Product Status 36
XI. 5 Next Generation Needles 36
XI. 5.1 Product Description 36
XI. 5.2 Product Status 37

XII Appendix 38
XII. 1 Methodology 38
XII. 1.1 Coverage 38
XII. 1.2 Secondary Research 39
XII. 1.3 Primary Research 39
XII. 1.4 Expert Panel Validation 40
XII. 2 Contact Us 40
XII. 3 About World March kets Direct 40
XII. 4 Disclaimer 40



I. 1 List of Data tables
Data table 1: November o Nordisk A/S,Key Facts 8
Data table 2: November o Nordisk A/S, Key Executives , 14
Data table 3: November o Nordisk A/S, Other Locations 20
Data table 4: November o Nordisk A/S, Subsidiaries 20
Data table 5: November o Nordisk A/S Pipeline Products by Equipment Type 33
Data table 6: November o Nordisk A/S Pipeline Products By Development Stage 34
Data table 7: November o Nordisk A/S Pipeline Products By Therapy Area 35



I. 2 List of Charts
Chart 1: November o Nordisk A/S Pipeline Products By Development Stage 34
Chart 2: World March kets Direct Methodology 38